糖尿病性神経障害の治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Diabetic Neuropathy Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04799
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※当調査レポートでは、糖尿病性神経障害の治療の世界市場について調査・分析し、糖尿病性神経障害の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（末梢神経障害、自律神経障害、近位神経障害、焦点性神経障害）、用途別（病院、診療所、薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の糖尿病性神経障害の治療市場動向
・主要企業別マーケットシェア
・糖尿病性神経障害の治療の種類別市場規模2014-2019
（末梢神経障害、自律神経障害、近位神経障害、焦点性神経障害）
・糖尿病性神経障害の治療の用途別市場規模2014-2019
（病院、診療所、薬局）
・糖尿病性神経障害の治療の北米市場：主要企業・種類別/用途別市場規模
・糖尿病性神経障害の治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・糖尿病性神経障害の治療の中国市場：主要企業・種類別/用途別市場規模
・糖尿病性神経障害の治療の日本国内市場：主要企業・種類別/用途別市場規模
・糖尿病性神経障害の治療の東南アジア市場：主要企業・種類別/用途別市場規模
・糖尿病性神経障害の治療のインド市場：主要企業・種類別/用途別市場規模
・糖尿病性神経障害の治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Abbott、Roche、Eli Lilly、Johnson & Johnson、GlaxoSmithKline、Lupin、Glenmark、Depomed、Astellas、Pfizer）
・糖尿病性神経障害の治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. Patients suffering from diabetes since a long time are prone to nerve damages throughout the body, as the symptoms of diabetic neuropathies cannot be diagnosed at an earlier stage.Although there is no cure for diabetic neuropathy, it can be suppressed or prevented using various treatment modalities.
In 2018, the global Diabetic Neuropathy Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Diabetic Neuropathy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Neuropathy Treatment development in United States, Europe and China.

The key players covered in this study
Abbott
Roche
Eli Lilly
Johnson & Johnson
GlaxoSmithKline
Lupin
Glenmark
Depomed
Astellas
Pfizer

Market segment by Type, the product can be split into
Peripheral Neuropathy
Autonomic Neuropathy
Proximal Neuropathy
Focal Neuropathy

Market segment by Application, split into
Hospitals
Clinics
Pharmacy

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Diabetic Neuropathy Treatment status, future forecast, growth opportunity, key market and key players.
To present the Diabetic Neuropathy Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Diabetic Neuropathy Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diabetic Neuropathy Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Peripheral Neuropathy
1.4.3 Autonomic Neuropathy
1.4.4 Proximal Neuropathy
1.4.5 Focal Neuropathy
1.5 Market by Application
1.5.1 Global Diabetic Neuropathy Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Diabetic Neuropathy Treatment Market Size
2.2 Diabetic Neuropathy Treatment Growth Trends by Regions
2.2.1 Diabetic Neuropathy Treatment Market Size by Regions (2014-2025)
2.2.2 Diabetic Neuropathy Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Diabetic Neuropathy Treatment Market Size by Manufacturers
3.1.1 Global Diabetic Neuropathy Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Diabetic Neuropathy Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Diabetic Neuropathy Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Neuropathy Treatment Key Players Head office and Area Served
3.3 Key Players Diabetic Neuropathy Treatment Product/Solution/Service
3.4 Date of Enter into Diabetic Neuropathy Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Diabetic Neuropathy Treatment Market Size by Type (2014-2019)
4.2 Global Diabetic Neuropathy Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Diabetic Neuropathy Treatment Market Size (2014-2019)
5.2 Diabetic Neuropathy Treatment Key Players in United States
5.3 United States Diabetic Neuropathy Treatment Market Size by Type
5.4 United States Diabetic Neuropathy Treatment Market Size by Application

6 Europe
6.1 Europe Diabetic Neuropathy Treatment Market Size (2014-2019)
6.2 Diabetic Neuropathy Treatment Key Players in Europe
6.3 Europe Diabetic Neuropathy Treatment Market Size by Type
6.4 Europe Diabetic Neuropathy Treatment Market Size by Application

7 China
7.1 China Diabetic Neuropathy Treatment Market Size (2014-2019)
7.2 Diabetic Neuropathy Treatment Key Players in China
7.3 China Diabetic Neuropathy Treatment Market Size by Type
7.4 China Diabetic Neuropathy Treatment Market Size by Application

8 Japan
8.1 Japan Diabetic Neuropathy Treatment Market Size (2014-2019)
8.2 Diabetic Neuropathy Treatment Key Players in Japan
8.3 Japan Diabetic Neuropathy Treatment Market Size by Type
8.4 Japan Diabetic Neuropathy Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Diabetic Neuropathy Treatment Market Size (2014-2019)
9.2 Diabetic Neuropathy Treatment Key Players in Southeast Asia
9.3 Southeast Asia Diabetic Neuropathy Treatment Market Size by Type
9.4 Southeast Asia Diabetic Neuropathy Treatment Market Size by Application

10 India
10.1 India Diabetic Neuropathy Treatment Market Size (2014-2019)
10.2 Diabetic Neuropathy Treatment Key Players in India
10.3 India Diabetic Neuropathy Treatment Market Size by Type
10.4 India Diabetic Neuropathy Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Diabetic Neuropathy Treatment Market Size (2014-2019)
11.2 Diabetic Neuropathy Treatment Key Players in Central & South America
11.3 Central & South America Diabetic Neuropathy Treatment Market Size by Type
11.4 Central & South America Diabetic Neuropathy Treatment Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diabetic Neuropathy Treatment Introduction
12.1.4 Abbott Revenue in Diabetic Neuropathy Treatment Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diabetic Neuropathy Treatment Introduction
12.2.4 Roche Revenue in Diabetic Neuropathy Treatment Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diabetic Neuropathy Treatment Introduction
12.3.4 Eli Lilly Revenue in Diabetic Neuropathy Treatment Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diabetic Neuropathy Treatment Introduction
12.4.4 Johnson & Johnson Revenue in Diabetic Neuropathy Treatment Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diabetic Neuropathy Treatment Introduction
12.5.4 GlaxoSmithKline Revenue in Diabetic Neuropathy Treatment Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Lupin
12.6.1 Lupin Company Details
12.6.2 Company Description and Business Overview
12.6.3 Diabetic Neuropathy Treatment Introduction
12.6.4 Lupin Revenue in Diabetic Neuropathy Treatment Business (2014-2019)
12.6.5 Lupin Recent Development
12.7 Glenmark
12.7.1 Glenmark Company Details
12.7.2 Company Description and Business Overview
12.7.3 Diabetic Neuropathy Treatment Introduction
12.7.4 Glenmark Revenue in Diabetic Neuropathy Treatment Business (2014-2019)
12.7.5 Glenmark Recent Development
12.8 Depomed
12.8.1 Depomed Company Details
12.8.2 Company Description and Business Overview
12.8.3 Diabetic Neuropathy Treatment Introduction
12.8.4 Depomed Revenue in Diabetic Neuropathy Treatment Business (2014-2019)
12.8.5 Depomed Recent Development
12.9 Astellas
12.9.1 Astellas Company Details
12.9.2 Company Description and Business Overview
12.9.3 Diabetic Neuropathy Treatment Introduction
12.9.4 Astellas Revenue in Diabetic Neuropathy Treatment Business (2014-2019)
12.9.5 Astellas Recent Development
12.10 Pfizer
12.10.1 Pfizer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Diabetic Neuropathy Treatment Introduction
12.10.4 Pfizer Revenue in Diabetic Neuropathy Treatment Business (2014-2019)
12.10.5 Pfizer Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Diabetic Neuropathy Treatment Key Market Segments
Table Key Players Diabetic Neuropathy Treatment Covered
Table Global Diabetic Neuropathy Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Diabetic Neuropathy Treatment Market Size Market Share by Type 2014-2025
Figure Peripheral Neuropathy Figures
Table Key Players of Peripheral Neuropathy
Figure Autonomic Neuropathy Figures
Table Key Players of Autonomic Neuropathy
Figure Proximal Neuropathy Figures
Table Key Players of Proximal Neuropathy
Figure Focal Neuropathy Figures
Table Key Players of Focal Neuropathy
Table Global Diabetic Neuropathy Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Pharmacy Case Studies
Figure Diabetic Neuropathy Treatment Report Years Considered
Table Global Diabetic Neuropathy Treatment Market Size 2014-2025 (Million US$)
Figure Global Diabetic Neuropathy Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Diabetic Neuropathy Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Diabetic Neuropathy Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Diabetic Neuropathy Treatment Market Share by Regions 2014-2019
Figure Global Diabetic Neuropathy Treatment Market Share by Regions 2014-2019
Figure Global Diabetic Neuropathy Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Diabetic Neuropathy Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Diabetic Neuropathy Treatment Market Share by Manufacturers (2014-2019)
Figure Global Diabetic Neuropathy Treatment Market Share by Manufacturers in 2018
Table Global Diabetic Neuropathy Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Diabetic Neuropathy Treatment Product/Solution/Service
Table Date of Enter into Diabetic Neuropathy Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Diabetic Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Diabetic Neuropathy Treatment Market Size Share by Type (2014-2019)
Figure Global Diabetic Neuropathy Treatment Market Size Market Share by Type (2014-2019)
Table Global Diabetic Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Diabetic Neuropathy Treatment Market Size Share by Application (2014-2019)
Figure Global Diabetic Neuropathy Treatment Market Size Market Share by Application (2014-2019)
Figure Global Diabetic Neuropathy Treatment Revenue Market Share by Application in 2018
Figure United States Diabetic Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Diabetic Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Diabetic Neuropathy Treatment Market Share (2018-2019)
Table United States Diabetic Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Diabetic Neuropathy Treatment Market Share by Type (2014-2019)
Table United States Diabetic Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Diabetic Neuropathy Treatment Market Share by Application (2014-2019)
Figure Europe Diabetic Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Diabetic Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Diabetic Neuropathy Treatment Market Share (2018-2019)
Table Europe Diabetic Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Diabetic Neuropathy Treatment Market Share by Type (2014-2019)
Table Europe Diabetic Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Diabetic Neuropathy Treatment Market Share by Application (2014-2019)
Figure China Diabetic Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Diabetic Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Diabetic Neuropathy Treatment Market Share (2018-2019)
Table China Diabetic Neuropathy Treatment Market Size by Type (2014-20189) (Million US$)
Table China Diabetic Neuropathy Treatment Market Share by Type (2014-2019)
Table China Diabetic Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table China Diabetic Neuropathy Treatment Market Share by Application (2014-2019)
Figure Japan Diabetic Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Diabetic Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Diabetic Neuropathy Treatment Market Share (2018-2019)
Table Japan Diabetic Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Diabetic Neuropathy Treatment Market Share by Type (2014-2019)
Table Japan Diabetic Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Diabetic Neuropathy Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Diabetic Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Diabetic Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Diabetic Neuropathy Treatment Market Share (2018-2019)
Table Southeast Asia Diabetic Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Diabetic Neuropathy Treatment Market Share by Type (2014-2019)
Table Southeast Asia Diabetic Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Diabetic Neuropathy Treatment Market Share by Application (2014-2019)
Figure India Diabetic Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Diabetic Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Diabetic Neuropathy Treatment Market Share (2018-2019)
Table India Diabetic Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table India Diabetic Neuropathy Treatment Market Share by Type (2014-2019)
Table India Diabetic Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table India Diabetic Neuropathy Treatment Market Share by Application (2014-2019)
Figure Central & South America Diabetic Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Diabetic Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Diabetic Neuropathy Treatment Market Share (2018-2019)
Table Central & South America Diabetic Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Diabetic Neuropathy Treatment Market Share by Type (2014-2019)
Table Central & South America Diabetic Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Diabetic Neuropathy Treatment Market Share by Application (2014-2019)
Table Abbott Company Details
Table Abbott Revenue in Diabetic Neuropathy Treatment Business (2014-2019) (Million US$)
Figure Abbott Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2014-2019)
Table Abbott Recent Development
Table Roche Company Details
Table Roche Revenue in Diabetic Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2014-2019)
Table Roche Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Diabetic Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Diabetic Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Diabetic Neuropathy Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Lupin Company Details
Table Lupin Revenue in Diabetic Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Lupin Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2014-2019)
Table Lupin Recent Development
Table Glenmark Company Details
Table Glenmark Revenue in Diabetic Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Glenmark Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2014-2019)
Table Glenmark Recent Development
Table Depomed Company Details
Table Depomed Revenue in Diabetic Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Depomed Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2014-2019)
Table Depomed Recent Development
Table Astellas Company Details
Table Astellas Revenue in Diabetic Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Astellas Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2014-2019)
Table Astellas Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Diabetic Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Diabetic Neuropathy Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Global Diabetic Neuropathy Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Diabetic Neuropathy Treatment Market Size Share by Regions (2019-2025)
Figure Global Diabetic Neuropathy Treatment Market Size Share by Regions in 2025
Figure United States Diabetic Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Diabetic Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Diabetic Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Diabetic Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Diabetic Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Diabetic Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Diabetic Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Diabetic Neuropathy Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Diabetic Neuropathy Treatment Market Size by Product (2019-2025)
Figure Global Diabetic Neuropathy Treatment Market Size by Product in 2025
Table Global Diabetic Neuropathy Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Diabetic Neuropathy Treatment Market Size by Application (2019-2025)
Figure Global Diabetic Neuropathy Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

糖尿病性網膜症の治療の世界市場：市場規模・現状・予測

Global Diabetic Retinopathy Treatment Market Size, Status and Forecast 2019-2025
QYR9ST03621 2019年9月2日 103Pages
※当調査レポートでは、糖尿病性網膜症の治療の世界市場について調査・分析し、糖尿病性網膜症の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（増殖性糖尿病性網膜症（PDR）、非増殖性糖尿病性網膜症（...

糖尿病性潰瘍の治療の世界市場：市場規模・現状・予測

Global Diabetic Ulcers Treatment Market Size, Status and Forecast 2019-2025
QYR9ST01238 2019年9月2日 96Pages
※当調査レポートでは、糖尿病性潰瘍の治療の世界市場について調査・分析し、糖尿病性潰瘍の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（足潰瘍、口潰瘍、皮膚潰瘍、角膜潰瘍）、用途別（病院、地域保健...

糖尿病性胃不全麻痺の治療の世界市場：市場規模・現状・予測

Global Diabetic Gastroparesis Treatment Market Size, Status and Forecast 2019-2025
QYR9ST04153 2019年9月2日 93Pages
※当調査レポートでは、糖尿病性胃不全麻痺の治療の世界市場について調査・分析し、糖尿病性胃不全麻痺の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物、外科治療製品）、用途別（薬物、外科治療製品...

糖尿病性足潰瘍の治療の世界市場：インサイト・予測

Global Diabetic Foot Ulcers Treatment Market Insights, Forecast to 2025
QYR9ST00122 2019年9月2日 114Pages
※本調査レポートでは、世界の糖尿病性足潰瘍の治療市場について調査・分析し、以下の構成でお届け致します。糖尿病性足潰瘍の治療の種類別には、創傷ケアドレッシング（フォームドレッシング、ハイドロコロイドドレッシング、ハイドロゲルドレッシング、アルギン酸ドレッシング、およびその他のドレッシング）、生物製剤（...

糖尿病治療の世界市場：市場規模・現状・予測

Global Diabetic Care Market Size, Status and Forecast 2019-2025
QYR9ST14549 2019年9月10日 93Pages
※当調査レポートでは、糖尿病治療の世界市場について調査・分析し、糖尿病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（Ⅰ型糖尿病（青少年発症糖尿病）、Ⅱ型糖尿病（成人発症糖尿病）、妊娠糖尿病）、...

糖尿病治療薬の世界市場：市場規模・現状・予測

Global Diabetic Therapeutic Market Size, Status and Forecast 2019-2025
QYR9ST03178 2019年9月2日 119Pages
※当調査レポートでは、糖尿病治療薬の世界市場について調査・分析し、糖尿病治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（タイプ1、タイプ2、妊娠）、用途別（インスリン療法、非インスリン療法）、...

糖尿病性網膜症の世界市場：市場規模・現状・予測

Global Diabetic Retinopathy Market Size, Status and Forecast 2019-2025
QYR9ST03177 2019年9月2日 114Pages
※当調査レポートでは、糖尿病性網膜症の世界市場について調査・分析し、糖尿病性網膜症の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（レーザー手術、コルチコステロイドの注射、抗VEGF薬の眼への注入、硝...

糖尿病注射ペンの世界市場：市場規模・現状・予測

Global Diabetic Injection Pens Market Size, Status and Forecast 2019-2025
QYR9ST02221 2019年9月2日 98Pages
※当調査レポートでは、糖尿病注射ペンの世界市場について調査・分析し、糖尿病注射ペンの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（再利用可能なペン、使い捨てペン）、用途別（病院薬局、小売薬局、オンラ...

糖尿病性腎症の世界市場：市場規模・現状・予測

Global Diabetic Nephropathy Market Size, Status and Forecast 2019-2025
QYR9ST04154 2019年9月2日 95Pages
※当調査レポートでは、糖尿病性腎症の世界市場について調査・分析し、糖尿病性腎症の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ACE阻害剤、ARB、利尿薬、カルシウムチャネル遮断薬（CCB）、レニン...

黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場：市場規模・現状・予測

Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, Status and Forecast 2019-2025
QYR9ST04929 2019年9月2日 91Pages
※当調査レポートでは、黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場について調査・分析し、黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（...

糖尿病性網膜症の治療の世界市場：市場規模・現状・予測 Diabetic retinopathy (die-uh-BET-ik ret-ih-NOP-uh-thee) is a diabetes complication that affects eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina).In 2018, the global Diabetic Retinopathy Treatment market size was xx million US$ and it is e…
糖尿病性胃不全麻痺の治療の世界市場：市場規模・現状・予測 Delayed gastric emptying associated with diabetes is known as Diabetic Gastroparesis (DGP). Though it occurs in patients suffering from both Type-1 and Type- 2 diabetes, it is more common in female patients suffering from Type-2 diabetes. The cause of DGP is inherent damage in the vagus nerve that c…
糖尿病性潰瘍の治療の世界市場：市場規模・現状・予測 Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot.In 2018, the global Diabetic Ulcers Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. Thi…
糖尿病性足潰瘍の治療の世界市場：インサイト・予測 Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper tre…
糖尿病及び関連疾患向け幹細胞療法の世界市場：市場規模・現状・予測 Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).NSI-566 is the stem cell therap…